Global geno-proteomic analysis reveals cross-continental sequence conservation and druggable sites among influenza virus polymerases
•Polymorphism analyses reveal 12% and 6% conservation among viral polymerase nucleotide and protein sequences resp.•Identified 29 conserved nucleotide regions can potentially be targeted for inhibitor designing.•Polymerases have undergone purifying mutations over past 6 decades resulting in their st...
Gespeichert in:
| Veröffentlicht in: | Antiviral research Jg. 112; S. 120 - 131 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Kidlington
Elsevier B.V
01.12.2014
Elsevier |
| Schlagworte: | |
| ISSN: | 0166-3542, 1872-9096, 1872-9096 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | •Polymorphism analyses reveal 12% and 6% conservation among viral polymerase nucleotide and protein sequences resp.•Identified 29 conserved nucleotide regions can potentially be targeted for inhibitor designing.•Polymerases have undergone purifying mutations over past 6 decades resulting in their steady molecular existence.•Based on continent-based host classification, a consistent geo-phylogenetic pattern is observed.•Conserved protein regions and drug pockets on polymerases indicate their preference for druggability.
Influenza virus is one of the major causes of mortality and morbidity associated with respiratory diseases. The high rate of mutation in the viral proteome provides it with the ability to survive in a variety of host species. This property helps it in maintaining and developing its pathogenicity, transmission and drug resistance. Alternate drug targets, particularly the internal proteins, can potentially be exploited for addressing the resistance issues. In the current analysis, the degree of conservation of influenza virus polymerases has been studied as one of the essential elements for establishing its candidature as a potential target of antiviral therapy. We analyzed more than 130,000 nucleotide and amino acid sequences by classifying them on the basis of continental presence of host organisms. Computational analyses including genetic polymorphism study, mutation pattern determination, molecular evolution and geophylogenetic analysis were performed to establish the high degree of conservation among the sequences. These studies lead to establishing the polymerases, in particular PB1, as highly conserved proteins. Moreover, we mapped the conservation percentage on the tertiary structures of proteins to identify the conserved, druggable sites. The research study, hence, revealed that the influenza virus polymerases are highly conserved (95–99%) proteins with a very slow mutation rate. Potential drug binding sites on various polymerases have also been reported. A scheme for drug target candidate development that can be employed to rapidly mutating proteins has been presented. Moreover, the research output can help in designing new therapeutic molecules against the identified targets. |
|---|---|
| AbstractList | Influenza virus is one of the major causes of mortality and morbidity associated with respiratory diseases. The high rate of mutation in the viral proteome provides it with the ability to survive in a variety of host species. This property helps it in maintaining and developing its pathogenicity, transmission and drug resistance. Alternate drug targets, particularly the internal proteins, can potentially be exploited for addressing the resistance issues. In the current analysis, the degree of conservation of influenza virus polymerases has been studied as one of the essential elements for establishing its candidature as a potential target of antiviral therapy. We analyzed more than 130,000 nucleotide and amino acid sequences by classifying them on the basis of continental presence of host organisms. Computational analyses including genetic polymorphism study, mutation pattern determination, molecular evolution and geophylogenetic analysis were performed to establish the high degree of conservation among the sequences. These studies lead to establishing the polymerases, in particular PB1, as highly conserved proteins. Moreover, we mapped the conservation percentage on the tertiary structures of proteins to identify the conserved, druggable sites. The research study, hence, revealed that the influenza virus polymerases are highly conserved (95-99%) proteins with a very slow mutation rate. Potential drug binding sites on various polymerases have also been reported. A scheme for drug target candidate development that can be employed to rapidly mutating proteins has been presented. Moreover, the research output can help in designing new therapeutic molecules against the identified targets. Influenza virus is one of the major causes of mortality and morbidity associated with respiratory diseases. The high rate of mutation in the viral proteome provides it with the ability to survive in a variety of host species. This property helps it in maintaining and developing its pathogenicity, transmission and drug resistance. Alternate drug targets, particularly the internal proteins, can potentially be exploited for addressing the resistance issues. In the current analysis, the degree of conservation of influenza virus polymerases has been studied as one of the essential elements for establishing its candidature as a potential target of antiviral therapy. We analyzed more than 130,000 nucleotide and amino acid sequences by classifying them on the basis of continental presence of host organisms. Computational analyses including genetic polymorphism study, mutation pattern determination, molecular evolution and geophylogenetic analysis were performed to establish the high degree of conservation among the sequences. These studies lead to establishing the polymerases, in particular PB1, as highly conserved proteins. Moreover, we mapped the conservation percentage on the tertiary structures of proteins to identify the conserved, druggable sites. The research study, hence, revealed that the influenza virus polymerases are highly conserved (95-99%) proteins with a very slow mutation rate. Potential drug binding sites on various polymerases have also been reported. A scheme for drug target candidate development that can be employed to rapidly mutating proteins has been presented. Moreover, the research output can help in designing new therapeutic molecules against the identified targets.Influenza virus is one of the major causes of mortality and morbidity associated with respiratory diseases. The high rate of mutation in the viral proteome provides it with the ability to survive in a variety of host species. This property helps it in maintaining and developing its pathogenicity, transmission and drug resistance. Alternate drug targets, particularly the internal proteins, can potentially be exploited for addressing the resistance issues. In the current analysis, the degree of conservation of influenza virus polymerases has been studied as one of the essential elements for establishing its candidature as a potential target of antiviral therapy. We analyzed more than 130,000 nucleotide and amino acid sequences by classifying them on the basis of continental presence of host organisms. Computational analyses including genetic polymorphism study, mutation pattern determination, molecular evolution and geophylogenetic analysis were performed to establish the high degree of conservation among the sequences. These studies lead to establishing the polymerases, in particular PB1, as highly conserved proteins. Moreover, we mapped the conservation percentage on the tertiary structures of proteins to identify the conserved, druggable sites. The research study, hence, revealed that the influenza virus polymerases are highly conserved (95-99%) proteins with a very slow mutation rate. Potential drug binding sites on various polymerases have also been reported. A scheme for drug target candidate development that can be employed to rapidly mutating proteins has been presented. Moreover, the research output can help in designing new therapeutic molecules against the identified targets. •Polymorphism analyses reveal 12% and 6% conservation among viral polymerase nucleotide and protein sequences resp.•Identified 29 conserved nucleotide regions can potentially be targeted for inhibitor designing.•Polymerases have undergone purifying mutations over past 6 decades resulting in their steady molecular existence.•Based on continent-based host classification, a consistent geo-phylogenetic pattern is observed.•Conserved protein regions and drug pockets on polymerases indicate their preference for druggability. Influenza virus is one of the major causes of mortality and morbidity associated with respiratory diseases. The high rate of mutation in the viral proteome provides it with the ability to survive in a variety of host species. This property helps it in maintaining and developing its pathogenicity, transmission and drug resistance. Alternate drug targets, particularly the internal proteins, can potentially be exploited for addressing the resistance issues. In the current analysis, the degree of conservation of influenza virus polymerases has been studied as one of the essential elements for establishing its candidature as a potential target of antiviral therapy. We analyzed more than 130,000 nucleotide and amino acid sequences by classifying them on the basis of continental presence of host organisms. Computational analyses including genetic polymorphism study, mutation pattern determination, molecular evolution and geophylogenetic analysis were performed to establish the high degree of conservation among the sequences. These studies lead to establishing the polymerases, in particular PB1, as highly conserved proteins. Moreover, we mapped the conservation percentage on the tertiary structures of proteins to identify the conserved, druggable sites. The research study, hence, revealed that the influenza virus polymerases are highly conserved (95–99%) proteins with a very slow mutation rate. Potential drug binding sites on various polymerases have also been reported. A scheme for drug target candidate development that can be employed to rapidly mutating proteins has been presented. Moreover, the research output can help in designing new therapeutic molecules against the identified targets. |
| Author | Babar, Mustafeez Mujtaba Tahir, Muhammad Zaidi, Najam-us-Sahar Sadaf |
| Author_xml | – sequence: 1 givenname: Mustafeez Mujtaba surname: Babar fullname: Babar, Mustafeez Mujtaba – sequence: 2 givenname: Najam-us-Sahar Sadaf surname: Zaidi fullname: Zaidi, Najam-us-Sahar Sadaf email: zaidi.sahar@gmail.com – sequence: 3 givenname: Muhammad surname: Tahir fullname: Tahir, Muhammad |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=29009647$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/25446404$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUFv1DAQhS1URLeFvwC-IHHJYidOsjlwqCooSJW4wNlynMnKK8dePM5Ky5kfzqS7BYlLOdmy3zdvZt4VuwgxAGNvpFhLIZv3u7UJ2R1cMn5dCqnodS1k9Yyt5KYti050zQVbkbIpqlqVl-wKcSeEaNpu84JdlrVSjRJqxX7d-dgbz7cQYrFPMUOcnOUmGH9EhzzBAYxHblNELGwk1wAhE4HwY4ZggdMjQjqY7GIgcOBDmrdb03vg6DIgN1MMW-7C6An4aTi1PSPfR3-cIBkEfMmej2QCr87nNfv-6eO328_F_de7L7c394VVlcoF1KrbdF1paSw19BV00tbVOIjeNgCg6k0lhKxH05bVOLZlo-giBrURVti-lNU1e3eqS4NS85j15NCC9yZAnFFLIoRsZdv-h7Si6o2oGpK-PkvnfoJB75ObTDrqxyWT4O1ZYNAaPyYTrMO_uk5QXGrx_HDSPSw7waityw9rzck4r6XQS_h6p_-Er5fwlw8Kn_j2H_7R4mny5kQCbf_gIGm0bgl3cAls1kN0T9b4Demz0Q8 |
| CODEN | ARSRDR |
| CitedBy_id | crossref_primary_10_1042_BST20160002 crossref_primary_10_1080_14789450_2022_2085564 crossref_primary_10_1016_j_apsb_2015_07_006 crossref_primary_10_1007_s10822_019_00189_w crossref_primary_10_1007_s00044_020_02561_0 |
| Cites_doi | 10.1016/j.antiviral.2013.09.015 10.1016/j.virusres.2013.05.010 10.1371/journal.pone.0076047 10.1093/heapol/czr056 10.1016/j.bmcl.2013.08.048 10.1128/AAC.00649-13 10.1093/nar/gkr487 10.1016/S1473-3099(12)70121-4 10.1074/jbc.M606494200 10.1371/journal.ppat.0030167 10.1038/nm1201-1306 10.1093/bioinformatics/bti320 10.1101/gr.095612.109 10.1021/ci200454v 10.1093/nar/25.17.3389 10.1038/nature07225 10.1073/pnas.0437841100 10.1016/j.antiviral.2007.12.010 10.1016/j.antiviral.2011.09.001 10.1097/CCM.0b013e3181ceb25b 10.1093/bioinformatics/bts310 10.2217/pgs.14.10 10.1007/s11434-012-5571-7 10.1016/S0168-9525(00)02024-2 10.1038/emboj.2009.138 10.1128/JVI.00724-07 10.1111/j.1461-0248.2011.01703.x 10.1093/molbev/msh194 10.1016/j.virol.2003.12.022 10.1128/AAC.39.11.2454 10.1371/journal.pone.0063270 10.1074/jbc.M112.392878 10.1002/bies.10303 10.1021/cb400400j 10.1021/jm401369y 10.2174/09298673113209990208 10.1093/bioinformatics/17.4.383 10.1016/j.virusres.2013.09.012 10.1111/j.1750-2659.2011.00331.x 10.1371/journal.pone.0061957 10.1371/journal.pone.0036113 10.1101/gr.849004 10.1371/journal.pone.0081027 10.1007/s00239-013-9557-0 10.1128/JVI.00980-13 10.1007/s13238-010-0008-z 10.1128/JVI.00496-11 10.1128/JVI.02656-12 10.1046/j.1365-2443.2001.00399.x 10.1016/j.virusres.2009.12.002 10.1021/jm500300r 10.1097/QCO.0b013e3283013945 10.1016/j.micinf.2011.01.013 10.1001/jama.292.11.1333 |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier B.V. 2015 INIST-CNRS Copyright © 2014 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2014 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright © 2014 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7T2 7T7 7U9 8FD C1K FR3 H94 P64 |
| DOI | 10.1016/j.antiviral.2014.10.013 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts Health & Safety Science Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Virology and AIDS Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1872-9096 |
| EndPage | 131 |
| ExternalDocumentID | 25446404 29009647 10_1016_j_antiviral_2014_10_013 S0166354214003064 |
| Genre | Research Support, Non-U.S. Gov't Meta-Analysis Journal Article |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATCM AAXUO ABBQC ABFNM ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CJTIS CNWQP CS3 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMG HVGLF HZ~ IHE J1W KOM LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSP SSZ T5K TEORI WUQ ZGI ZXP ~G- 9DU AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD IQODW CGR CUY CVF ECM EIF NPM 7X8 7T2 7T7 7U9 8FD C1K FR3 H94 P64 |
| ID | FETCH-LOGICAL-c434t-e5498992c1664db3e91c53fd0bc6eee45830015fa723ff72647230d480c0cb213 |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000346943900012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0166-3542 1872-9096 |
| IngestDate | Tue Oct 07 09:39:21 EDT 2025 Wed Oct 01 13:42:07 EDT 2025 Thu Apr 03 07:12:13 EDT 2025 Wed Apr 02 07:18:32 EDT 2025 Sat Nov 29 02:50:39 EST 2025 Tue Nov 18 21:59:15 EST 2025 Fri Feb 23 02:28:27 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Influenza protein druggability Influenza polymerases Geotemporal sequence conservation Drug targets Influenza virus Conservation Orthomyxoviridae Influenzavirus Protein Infection Virus Viral disease Analysis Influenza Targeted drug Proteomics |
| Language | English |
| License | CC BY 4.0 Copyright © 2014 Elsevier B.V. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c434t-e5498992c1664db3e91c53fd0bc6eee45830015fa723ff72647230d480c0cb213 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 25446404 |
| PQID | 1634726036 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_1647017177 proquest_miscellaneous_1634726036 pubmed_primary_25446404 pascalfrancis_primary_29009647 crossref_citationtrail_10_1016_j_antiviral_2014_10_013 crossref_primary_10_1016_j_antiviral_2014_10_013 elsevier_sciencedirect_doi_10_1016_j_antiviral_2014_10_013 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-12-01 |
| PublicationDateYYYYMMDD | 2014-12-01 |
| PublicationDate_xml | – month: 12 year: 2014 text: 2014-12-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: Netherlands |
| PublicationTitle | Antiviral research |
| PublicationTitleAlternate | Antiviral Res |
| PublicationYear | 2014 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Bradel-Tretheway, Mattiacio, Krasnoselsky, Stevenson, Purdy, Dewhurst, Katze (b0015) 2011; 85 Bruns, Studtrucker, Sharma, Fossen, Mitzner, Eissmann, Tessmer, Röder, Henklein, Wray (b0020) 2007; 282 Pond, Frost (b0160) 2005; 21 Muramoto, Noda, Kawakami, Akkina, Kawaoka (b0130) 2013; 87 Vincent, Miller (b0220) 2013; 87 Chen, Calvo, Malide, Gibbs, Schubert, Bacik, Basta, O’Neill, Schickli, Palese (b0025) 2001; 7 Zmasek, Eddy (b0260) 2001; 17 Krauss, Obert, Franks, Walker, Jones, Seiler, Niles, Pryor, Obenauer, Naeve (b0080) 2007; 3 Kumaki, Day, Smee, Morrey, Barnard (b9020) 2011; 92 Pongcharoensuk, Adisasmito, Silkavute, Muchlisoh, Hoat, Coker (b0170) 2012; 27 Yamamoto, Sakoda, Okamatsu, Kida (b0255) 2013; 178 Wang, Susko, Roger (b0235) 2013; 76 Baigent, McCauley (b0010) 2003; 25 Furuta, Gowen, Takahashi, Shiraki, Smee, Barnard (b9005) 2013; 100 Warren, Wan, Conant, Korkin (b0240) 2013; 8 Volkamer, Kuhn, Rippmann, Rarey (b0230) 2012; 28 Guan, Vijaykrishna, Bahl, Zhu, Wang, Smith (b0065) 2010; 1 Shi, Xie, Shi, Xu (b0185) 2013; 20 Thompson, Shay, Weintraub, Brammer, Bridges, Cox, Fukuda (b0200) 2004; 292 Ghanem, Mayer, Chase, Tegge, Frank, Kochs, García-Sastre, Schwemmle (b0060) 2007; 81 Sangawa, Komeno, Nishikawa, Yoshida, Takahashi, Nomura, Furuta (b9040) 2013; 57 Tisdale, Ellis, Klumpp, Ford (b9045) 1995; 39 Volkamer, Kuhn, Grombacher, Rippmann, Rarey (b0225) 2012; 52 Lin, Chiu, Lin, Cheng, Wu, Salemi, Liu (b0090) 2013; 8 Mayrose, Graur, Ben-Tal, Pupko (b0120) 2004; 21 Rice, Longden, Bleasby (b0180) 2000; 16 Hara, Shiota, Kido, Ohtsu, Kashiwagi, Iwahashi, Hamada, Mizoue, Tsumura, Kato (b0075) 2001; 6 van der Vries (b0215) 2014 Squires, Noronha, Hunt, García-Sastre, Macken, Baumgarth, Suarez, Pickett, Zhang, Larsen (b0190) 2012; 6 Crooks, Hon, Chandonia, Brenner (b0035) 2004; 14 Lam, Ip, Ghedin, Wentworth, Halpin, Stockwell, Spiro, Dusek, Bortner, Hoskins (b0085) 2012; 15 Liu, Qin, Meng, Zhang, Zhou, Zhao, Luo, Zheng (b0100) 2013; 288 Kessler, Castagnolo, Pagano, Deodato, Bernardini, Pilger, Ranadheera, Botta (b9015) 2013; 23 Sugiyama, Obayashi, Kawaguchi, Suzuki, Tame, Nagata, Park (b0195) 2009; 28 Mänz, Schwemmle, Brunotte (b0115) 2013; 87 Tønnessen, Hauge, Hansen, Rimstad, Jonassen (b0205) 2013; 8 Altschul, Madden, Schäffer, Zhang, Zhang, Miller, Lipman (b0005) 1997; 25 Lowen, Steel (b0105) 2014 Tsai, Chen (b0210) 2011; 13 Parra, Suarez-Kurtz (b0145) 2014; 15 Poole, Elton, Medcalf, Digard (b0175) 2004; 321 Chu, Fan, Li, Macken, Kim, Hatta, Neumann, Kawaoka (b0030) 2012; 7 Gabriel, Czudai-Matwich, Klenk (b0055) 2013; 178 Hall (b0070) 1999 Nakazawa, Kadowaki, Watanabe, Kadowaki, Takei, Fukuda (b9030) 2008; 78 Morens, Taubenberger, Harvey, Memoli (b0125) 2010; 38 Pearce, Ramey, Ip, Gill (b0155) 2010; 148 Fonville, Burke, Lewis, Katzelnick, Russell (b0050) 2013; 8 Ge, McManus, Nguyen, Shen, Sharp, Eisen, Chen (b9010) 2003; 100 Xiao, Tian, Lin, Gao, Dai, Zhang, Chen, Zhao, Xu (b0250) 2013; 58 Pautus, Sehr, Lewis, Fortune, Wolkerstorfer, Szolar, Guilligay, Lunardi, Decout, Cusack (b9035) 2013; 56 Maltezou (b0110) 2008; 21 Wise, Barbezange, Jagger, Dalton, Gog, Curran, Taubenberger, Anderson, Digard (b0245) 2011; 39 Bauman, Patel, Baker, Vijayan, Xiang, Parhi, Martínez-Sobrido, LaVoie, Das, Arnold (b9000) 2013; 8 El Hefnawi, AlAidi, Mohamed, Kamar, El-Azab, Zada, Siam (b0045) 2011; 8 Obayashi, Yoshida, Kawai, Shibayama, Kawaguchi, Nagata, Tame, Park (b0135) 2008; 454 Pazani, Karimi, Bozorgmehri Fard, Ghalyanchi Langeroudi, Barin (b0150) 2011; 12 Parks, Porter, Churcher, Wang, Blouin, Whalley, Brooks, Beiko (b0140) 2009; 19 Litwin, Jores (b0265) 1992 Pond, Muse (b0165) 2005 Dawood, Iuliano, Reed, Meltzer, Shay, Cheng, Bandaranayake, Breiman, Brooks, Buchy (b0040) 2012; 12 Lepri, Nannetti, Muratore, Cruciani, Ruzziconi, Mercorelli, Palù, Loregian, Goracci (b9025) 2014; 57 Parks (10.1016/j.antiviral.2014.10.013_b0140) 2009; 19 Pond (10.1016/j.antiviral.2014.10.013_b0165) 2005 Tisdale (10.1016/j.antiviral.2014.10.013_b9045) 1995; 39 Tønnessen (10.1016/j.antiviral.2014.10.013_b0205) 2013; 8 Pond (10.1016/j.antiviral.2014.10.013_b0160) 2005; 21 Hara (10.1016/j.antiviral.2014.10.013_b0075) 2001; 6 Thompson (10.1016/j.antiviral.2014.10.013_b0200) 2004; 292 Altschul (10.1016/j.antiviral.2014.10.013_b0005) 1997; 25 Crooks (10.1016/j.antiviral.2014.10.013_b0035) 2004; 14 Mänz (10.1016/j.antiviral.2014.10.013_b0115) 2013; 87 Wang (10.1016/j.antiviral.2014.10.013_b0235) 2013; 76 Krauss (10.1016/j.antiviral.2014.10.013_b0080) 2007; 3 Muramoto (10.1016/j.antiviral.2014.10.013_b0130) 2013; 87 Maltezou (10.1016/j.antiviral.2014.10.013_b0110) 2008; 21 Ghanem (10.1016/j.antiviral.2014.10.013_b0060) 2007; 81 Nakazawa (10.1016/j.antiviral.2014.10.013_b9030) 2008; 78 van der Vries (10.1016/j.antiviral.2014.10.013_b0215) 2014 Gabriel (10.1016/j.antiviral.2014.10.013_b0055) 2013; 178 Warren (10.1016/j.antiviral.2014.10.013_b0240) 2013; 8 Kessler (10.1016/j.antiviral.2014.10.013_b9015) 2013; 23 Litwin (10.1016/j.antiviral.2014.10.013_b0265) 1992 Zmasek (10.1016/j.antiviral.2014.10.013_b0260) 2001; 17 Guan (10.1016/j.antiviral.2014.10.013_b0065) 2010; 1 Obayashi (10.1016/j.antiviral.2014.10.013_b0135) 2008; 454 Sugiyama (10.1016/j.antiviral.2014.10.013_b0195) 2009; 28 Squires (10.1016/j.antiviral.2014.10.013_b0190) 2012; 6 Bruns (10.1016/j.antiviral.2014.10.013_b0020) 2007; 282 Lepri (10.1016/j.antiviral.2014.10.013_b9025) 2014; 57 Pongcharoensuk (10.1016/j.antiviral.2014.10.013_b0170) 2012; 27 Volkamer (10.1016/j.antiviral.2014.10.013_b0225) 2012; 52 El Hefnawi (10.1016/j.antiviral.2014.10.013_b0045) 2011; 8 Sangawa (10.1016/j.antiviral.2014.10.013_b9040) 2013; 57 Baigent (10.1016/j.antiviral.2014.10.013_b0010) 2003; 25 Dawood (10.1016/j.antiviral.2014.10.013_b0040) 2012; 12 Mayrose (10.1016/j.antiviral.2014.10.013_b0120) 2004; 21 Chu (10.1016/j.antiviral.2014.10.013_b0030) 2012; 7 Bradel-Tretheway (10.1016/j.antiviral.2014.10.013_b0015) 2011; 85 Ge (10.1016/j.antiviral.2014.10.013_b9010) 2003; 100 Yamamoto (10.1016/j.antiviral.2014.10.013_b0255) 2013; 178 Kumaki (10.1016/j.antiviral.2014.10.013_b9020) 2011; 92 Fonville (10.1016/j.antiviral.2014.10.013_b0050) 2013; 8 Volkamer (10.1016/j.antiviral.2014.10.013_b0230) 2012; 28 Liu (10.1016/j.antiviral.2014.10.013_b0100) 2013; 288 Lowen (10.1016/j.antiviral.2014.10.013_b0105) 2014 Lam (10.1016/j.antiviral.2014.10.013_b0085) 2012; 15 Pazani (10.1016/j.antiviral.2014.10.013_b0150) 2011; 12 Hall (10.1016/j.antiviral.2014.10.013_b0070) 1999 Vincent (10.1016/j.antiviral.2014.10.013_b0220) 2013; 87 Chen (10.1016/j.antiviral.2014.10.013_b0025) 2001; 7 Xiao (10.1016/j.antiviral.2014.10.013_b0250) 2013; 58 Bauman (10.1016/j.antiviral.2014.10.013_b9000) 2013; 8 Pearce (10.1016/j.antiviral.2014.10.013_b0155) 2010; 148 Parra (10.1016/j.antiviral.2014.10.013_b0145) 2014; 15 Furuta (10.1016/j.antiviral.2014.10.013_b9005) 2013; 100 Pautus (10.1016/j.antiviral.2014.10.013_b9035) 2013; 56 Poole (10.1016/j.antiviral.2014.10.013_b0175) 2004; 321 Tsai (10.1016/j.antiviral.2014.10.013_b0210) 2011; 13 Shi (10.1016/j.antiviral.2014.10.013_b0185) 2013; 20 Rice (10.1016/j.antiviral.2014.10.013_b0180) 2000; 16 Lin (10.1016/j.antiviral.2014.10.013_b0090) 2013; 8 Wise (10.1016/j.antiviral.2014.10.013_b0245) 2011; 39 Morens (10.1016/j.antiviral.2014.10.013_b0125) 2010; 38 |
| References_xml | – volume: 21 start-page: 1781 year: 2004 end-page: 1791 ident: b0120 article-title: Comparison of site-specific rate-inference methods for protein sequences: empirical Bayesian methods are superior publication-title: Mol. Biol. Evol. – volume: 87 start-page: 2455 year: 2013 end-page: 2462 ident: b0130 article-title: Identification of novel influenza A virus proteins translated from PA mRNA publication-title: J. Virol. – volume: 23 start-page: 5575 year: 2013 end-page: 5577 ident: b9015 article-title: Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus publication-title: Bioorg. Med. Chem. Lett. – volume: 15 start-page: 253 year: 2014 end-page: 256 ident: b0145 article-title: Demographic history and human genetic diversity: pharmacogenomic implications publication-title: Pharmacogenomics – volume: 8 start-page: e81027 year: 2013 ident: b0240 article-title: Extreme evolutionary conservation of functionally important regions in H1N1 influenza proteome publication-title: PLoS One – volume: 21 start-page: 337 year: 2008 end-page: 343 ident: b0110 article-title: Nosocomial influenza: new concepts and practice publication-title: Curr. Opin. Infect. Dis. – volume: 14 start-page: 1188 year: 2004 end-page: 1190 ident: b0035 article-title: WebLogo: a sequence logo generator publication-title: Genome Res. – volume: 17 start-page: 383 year: 2001 end-page: 384 ident: b0260 article-title: ATV: display and manipulation of annotated phylogenetic trees publication-title: Bioinformatics – volume: 76 start-page: 280 year: 2013 end-page: 294 ident: b0235 article-title: The Site-Wise Log-Likelihood score is a good predictor of genes under positive selection publication-title: J. Mol. Evol. – year: 2014 ident: b0215 article-title: Influenza resistance to antiviral drugs: virus characterization, mechanism and clinical impact – volume: 6 start-page: 87 year: 2001 end-page: 97 ident: b0075 article-title: Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site publication-title: Genes Cells – volume: 56 start-page: 8915 year: 2013 end-page: 8930 ident: b9035 article-title: New 7-methyl-guanosine derivatives targeting the influenza polymerase PB2 cap-binding domain publication-title: J. Med. Chem. – volume: 16 start-page: 276 year: 2000 end-page: 277 ident: b0180 article-title: EMBOSS: the European molecular biology open software suite publication-title: Trends Genet. – volume: 28 start-page: 1803 year: 2009 end-page: 1811 ident: b0195 article-title: Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymerase publication-title: EMBO J. – year: 1992 ident: b0265 publication-title: Shannon information as a measure of amino acid diversity – volume: 12 start-page: 687 year: 2012 end-page: 695 ident: b0040 article-title: Estimated global mortality associated with the first 12 publication-title: Lancet Infect. Dis. – volume: 27 start-page: 374 year: 2012 end-page: 383 ident: b0170 article-title: Avian and pandemic human influenza policy in South-East Asia: the interface between economic and public health imperatives publication-title: Health Policy Plan. – volume: 8 start-page: e76047 year: 2013 ident: b0050 article-title: Quantifying the fitness advantage of polymerase substitutions in influenza A/H7N9 viruses during adaptation to humans publication-title: PLoS One – volume: 25 start-page: 657 year: 2003 end-page: 671 ident: b0010 article-title: Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission publication-title: BioEssays – volume: 81 start-page: 7801 year: 2007 end-page: 7804 ident: b0060 article-title: Peptide-mediated interference with influenza A virus polymerase publication-title: J. Virol. – volume: 12 start-page: 324 year: 2011 end-page: 331 ident: b0150 article-title: Phylogenetic analysis of PB2 gene of H9N2 subtype of avian influenza viruses isolated from commercial chickens in Tehran province of Iran during 1998–2001 publication-title: Iran. J. Veter. Res. Shiraz. Univ. – volume: 321 start-page: 120 year: 2004 end-page: 133 ident: b0175 article-title: Functional domains of the influenza A virus PB2 protein: identification of NP-and PB1-binding sites publication-title: Virology – volume: 38 start-page: e10 year: 2010 ident: b0125 article-title: The 1918 influenza pandemic: lessons for 2009 and the future publication-title: Crit. Care Med. – volume: 178 start-page: 404 year: 2013 end-page: 410 ident: b0255 article-title: Polymerase complex with lysine at position 627 of the PB2 of influenza virus A/Hong Kong/483/97 (H5N1) efficiently transcribes and replicates virus genes in mouse cells publication-title: Virus Res. – start-page: 03513 year: 2014 end-page: 03544 ident: b0105 article-title: Roles of humidity and temperature in shaping influenza seasonality publication-title: J. Virol. – volume: 25 start-page: 3389 year: 1997 end-page: 3402 ident: b0005 article-title: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs publication-title: Nucleic Acids Res. – volume: 87 start-page: 10687 year: 2013 ident: b0220 article-title: Influenza A virus PB1-F2 protein publication-title: J. Virol. – start-page: 125 year: 2005 end-page: 181 ident: b0165 publication-title: HyPhy: hypothesis testing using phylogenies – volume: 8 start-page: 2501 year: 2013 end-page: 2508 ident: b9000 article-title: Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors publication-title: ACS Chem. Biol. – volume: 100 start-page: 446 year: 2013 end-page: 454 ident: b9005 article-title: Favipiravir (T-705), a novel viral RNA polymerase inhibitor publication-title: Antiviral Res. – volume: 282 start-page: 353 year: 2007 end-page: 363 ident: b0020 article-title: Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein publication-title: J. Biol. Chem. – volume: 57 start-page: 5202 year: 2013 end-page: 5208 ident: b9040 article-title: Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase publication-title: Antimicrob. Agents Chemother. – volume: 6 start-page: 404 year: 2012 end-page: 416 ident: b0190 article-title: Influenza research database: an integrated bioinformatics resource for influenza research and surveillance publication-title: Influenza Other Respir. Viruses – start-page: 95 year: 1999 end-page: 98 ident: b0070 article-title: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT publication-title: Nucleic Acids Symp. Ser. – volume: 92 start-page: 329 year: 2011 end-page: 340 ident: b9020 article-title: and publication-title: Antiviral Res. – volume: 52 start-page: 360 year: 2012 end-page: 372 ident: b0225 article-title: Combining global and local measures for structure-based druggability predictions publication-title: J. Chem. Inf. Model. – volume: 1 start-page: 9 year: 2010 end-page: 13 ident: b0065 article-title: The emergence of pandemic influenza viruses publication-title: Protein & Cell – volume: 85 start-page: 8569 year: 2011 end-page: 8581 ident: b0015 article-title: Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors publication-title: J. Virol. – volume: 178 start-page: 53 year: 2013 end-page: 62 ident: b0055 article-title: Adaptive mutations in the H5N1 polymerase complex publication-title: Virus Res. – volume: 39 start-page: 2454 year: 1995 end-page: 2458 ident: b9045 article-title: Inhibition of influenza virus transcription by 2′-deoxy-2′-fluoroguanosine publication-title: Antimicrob. Agents Chemother. – volume: 39 start-page: 7775 year: 2011 end-page: 7790 ident: b0245 article-title: Overlapping signals for translational regulation and packaging of influenza A virus segment 2 publication-title: Nucleic Acids Res. – volume: 3 start-page: e167 year: 2007 ident: b0080 article-title: Influenza in migratory birds and evidence of limited intercontinental virus exchange publication-title: PLoS Pathog. – volume: 28 start-page: 2074 year: 2012 end-page: 2075 ident: b0230 article-title: DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment publication-title: Bioinformatics – volume: 58 start-page: 741 year: 2013 end-page: 749 ident: b0250 article-title: Influence of extreme weather and meteorological anomalies on outbreaks of influenza A (H1N1) publication-title: Chin. Sci. Bull. – volume: 78 start-page: 194 year: 2008 end-page: 201 ident: b9030 article-title: PA subunit of RNA polymerase as a promising target for anti-influenza virus agents publication-title: Antiviral Res. – volume: 100 start-page: 2718 year: 2003 end-page: 2723 ident: b9010 article-title: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 15 start-page: 24 year: 2012 end-page: 33 ident: b0085 article-title: Migratory flyway and geographical distance are barriers to the gene flow of influenza virus among North American birds publication-title: Ecol. Lett. – volume: 20 start-page: 3923 year: 2013 end-page: 3934 ident: b0185 article-title: Viral RNA polymerase: a promising antiviral target for influenza A virus publication-title: Curr. Med. Chem. – volume: 19 start-page: 1896 year: 2009 end-page: 1904 ident: b0140 article-title: GenGIS: a geospatial information system for genomic data publication-title: Genome Res. – volume: 8 start-page: e61957 year: 2013 ident: b0090 article-title: Exploring the molecular epidemiology and evolutionary dynamics of influenza A virus in Taiwan publication-title: PLoS One – volume: 87 start-page: 7200 year: 2013 end-page: 7209 ident: b0115 article-title: Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier publication-title: J. Virol. – volume: 8 start-page: e63270 year: 2013 ident: b0205 article-title: Host restrictions of avian influenza viruses: publication-title: PLoS One – volume: 7 start-page: e36113 year: 2012 ident: b0030 article-title: Functional analysis of conserved motifs in influenza virus PB1 protein publication-title: PLoS ONE – volume: 13 start-page: 479 year: 2011 end-page: 488 ident: b0210 article-title: Influenza genome diversity and evolution publication-title: Microbes Infect. – volume: 454 start-page: 1127 year: 2008 end-page: 1131 ident: b0135 article-title: The structural basis for an essential subunit interaction in influenza virus RNA polymerase publication-title: Nature – volume: 288 start-page: 11013 year: 2013 end-page: 11023 ident: b0100 article-title: Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus publication-title: J. Biol. Chem. – volume: 148 start-page: 44 year: 2010 end-page: 50 ident: b0155 article-title: Limited evidence of trans-hemispheric movement of avian influenza viruses among contemporary North American shorebird isolates publication-title: Virus Res. – volume: 57 start-page: 4337 year: 2014 end-page: 4350 ident: b9025 article-title: Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds publication-title: J. Med. Chem. – volume: 292 start-page: 1333 year: 2004 end-page: 1340 ident: b0200 article-title: Influenza-associated hospitalizations in the United States publication-title: JAMA – volume: 8 start-page: 94 year: 2011 end-page: 98 ident: b0045 article-title: Identification of novel conserved functional motifs across most influenza A viral strains publication-title: Virol. J. – volume: 7 start-page: 1306 year: 2001 end-page: 1312 ident: b0025 article-title: A novel influenza A virus mitochondrial protein that induces cell death publication-title: Nat. Med. – volume: 21 start-page: 2531 year: 2005 end-page: 2533 ident: b0160 article-title: Datamonkey: rapid detection of selective pressure on individual sites of codon alignments publication-title: Bioinformatics – volume: 100 start-page: 446 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b9005 article-title: Favipiravir (T-705), a novel viral RNA polymerase inhibitor publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2013.09.015 – volume: 87 start-page: 10687 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0220 article-title: Influenza A virus PB1-F2 protein publication-title: J. Virol. – volume: 178 start-page: 53 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0055 article-title: Adaptive mutations in the H5N1 polymerase complex publication-title: Virus Res. doi: 10.1016/j.virusres.2013.05.010 – start-page: 95 year: 1999 ident: 10.1016/j.antiviral.2014.10.013_b0070 article-title: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT publication-title: Nucleic Acids Symp. Ser. – volume: 8 start-page: e76047 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0050 article-title: Quantifying the fitness advantage of polymerase substitutions in influenza A/H7N9 viruses during adaptation to humans publication-title: PLoS One doi: 10.1371/journal.pone.0076047 – start-page: 125 year: 2005 ident: 10.1016/j.antiviral.2014.10.013_b0165 – volume: 27 start-page: 374 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0170 article-title: Avian and pandemic human influenza policy in South-East Asia: the interface between economic and public health imperatives publication-title: Health Policy Plan. doi: 10.1093/heapol/czr056 – volume: 23 start-page: 5575 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b9015 article-title: Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2013.08.048 – volume: 57 start-page: 5202 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b9040 article-title: Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00649-13 – volume: 39 start-page: 7775 year: 2011 ident: 10.1016/j.antiviral.2014.10.013_b0245 article-title: Overlapping signals for translational regulation and packaging of influenza A virus segment 2 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkr487 – volume: 12 start-page: 687 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0040 article-title: Estimated global mortality associated with the first 12months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(12)70121-4 – year: 1992 ident: 10.1016/j.antiviral.2014.10.013_b0265 – volume: 282 start-page: 353 year: 2007 ident: 10.1016/j.antiviral.2014.10.013_b0020 article-title: Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein publication-title: J. Biol. Chem. doi: 10.1074/jbc.M606494200 – volume: 3 start-page: e167 year: 2007 ident: 10.1016/j.antiviral.2014.10.013_b0080 article-title: Influenza in migratory birds and evidence of limited intercontinental virus exchange publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.0030167 – volume: 7 start-page: 1306 year: 2001 ident: 10.1016/j.antiviral.2014.10.013_b0025 article-title: A novel influenza A virus mitochondrial protein that induces cell death publication-title: Nat. Med. doi: 10.1038/nm1201-1306 – volume: 21 start-page: 2531 year: 2005 ident: 10.1016/j.antiviral.2014.10.013_b0160 article-title: Datamonkey: rapid detection of selective pressure on individual sites of codon alignments publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti320 – volume: 19 start-page: 1896 year: 2009 ident: 10.1016/j.antiviral.2014.10.013_b0140 article-title: GenGIS: a geospatial information system for genomic data publication-title: Genome Res. doi: 10.1101/gr.095612.109 – volume: 52 start-page: 360 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0225 article-title: Combining global and local measures for structure-based druggability predictions publication-title: J. Chem. Inf. Model. doi: 10.1021/ci200454v – volume: 25 start-page: 3389 year: 1997 ident: 10.1016/j.antiviral.2014.10.013_b0005 article-title: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs publication-title: Nucleic Acids Res. doi: 10.1093/nar/25.17.3389 – volume: 454 start-page: 1127 year: 2008 ident: 10.1016/j.antiviral.2014.10.013_b0135 article-title: The structural basis for an essential subunit interaction in influenza virus RNA polymerase publication-title: Nature doi: 10.1038/nature07225 – volume: 100 start-page: 2718 year: 2003 ident: 10.1016/j.antiviral.2014.10.013_b9010 article-title: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0437841100 – volume: 78 start-page: 194 year: 2008 ident: 10.1016/j.antiviral.2014.10.013_b9030 article-title: PA subunit of RNA polymerase as a promising target for anti-influenza virus agents publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2007.12.010 – year: 2014 ident: 10.1016/j.antiviral.2014.10.013_b0215 – volume: 92 start-page: 329 year: 2011 ident: 10.1016/j.antiviral.2014.10.013_b9020 article-title: In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2011.09.001 – volume: 38 start-page: e10 year: 2010 ident: 10.1016/j.antiviral.2014.10.013_b0125 article-title: The 1918 influenza pandemic: lessons for 2009 and the future publication-title: Crit. Care Med. doi: 10.1097/CCM.0b013e3181ceb25b – volume: 28 start-page: 2074 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0230 article-title: DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment publication-title: Bioinformatics doi: 10.1093/bioinformatics/bts310 – volume: 15 start-page: 253 year: 2014 ident: 10.1016/j.antiviral.2014.10.013_b0145 article-title: Demographic history and human genetic diversity: pharmacogenomic implications publication-title: Pharmacogenomics doi: 10.2217/pgs.14.10 – volume: 58 start-page: 741 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0250 article-title: Influence of extreme weather and meteorological anomalies on outbreaks of influenza A (H1N1) publication-title: Chin. Sci. Bull. doi: 10.1007/s11434-012-5571-7 – volume: 16 start-page: 276 year: 2000 ident: 10.1016/j.antiviral.2014.10.013_b0180 article-title: EMBOSS: the European molecular biology open software suite publication-title: Trends Genet. doi: 10.1016/S0168-9525(00)02024-2 – volume: 28 start-page: 1803 year: 2009 ident: 10.1016/j.antiviral.2014.10.013_b0195 article-title: Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymerase publication-title: EMBO J. doi: 10.1038/emboj.2009.138 – volume: 81 start-page: 7801 year: 2007 ident: 10.1016/j.antiviral.2014.10.013_b0060 article-title: Peptide-mediated interference with influenza A virus polymerase publication-title: J. Virol. doi: 10.1128/JVI.00724-07 – volume: 15 start-page: 24 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0085 article-title: Migratory flyway and geographical distance are barriers to the gene flow of influenza virus among North American birds publication-title: Ecol. Lett. doi: 10.1111/j.1461-0248.2011.01703.x – start-page: 03513 year: 2014 ident: 10.1016/j.antiviral.2014.10.013_b0105 article-title: Roles of humidity and temperature in shaping influenza seasonality publication-title: J. Virol. – volume: 21 start-page: 1781 year: 2004 ident: 10.1016/j.antiviral.2014.10.013_b0120 article-title: Comparison of site-specific rate-inference methods for protein sequences: empirical Bayesian methods are superior publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msh194 – volume: 321 start-page: 120 year: 2004 ident: 10.1016/j.antiviral.2014.10.013_b0175 article-title: Functional domains of the influenza A virus PB2 protein: identification of NP-and PB1-binding sites publication-title: Virology doi: 10.1016/j.virol.2003.12.022 – volume: 39 start-page: 2454 year: 1995 ident: 10.1016/j.antiviral.2014.10.013_b9045 article-title: Inhibition of influenza virus transcription by 2′-deoxy-2′-fluoroguanosine publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.39.11.2454 – volume: 8 start-page: e63270 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0205 article-title: Host restrictions of avian influenza viruses: in silico analysis of H13 and H16 specific signatures in the internal proteins publication-title: PLoS One doi: 10.1371/journal.pone.0063270 – volume: 288 start-page: 11013 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0100 article-title: Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.392878 – volume: 25 start-page: 657 year: 2003 ident: 10.1016/j.antiviral.2014.10.013_b0010 article-title: Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission publication-title: BioEssays doi: 10.1002/bies.10303 – volume: 8 start-page: 2501 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b9000 article-title: Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors publication-title: ACS Chem. Biol. doi: 10.1021/cb400400j – volume: 12 start-page: 324 year: 2011 ident: 10.1016/j.antiviral.2014.10.013_b0150 article-title: Phylogenetic analysis of PB2 gene of H9N2 subtype of avian influenza viruses isolated from commercial chickens in Tehran province of Iran during 1998–2001 publication-title: Iran. J. Veter. Res. Shiraz. Univ. – volume: 56 start-page: 8915 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b9035 article-title: New 7-methyl-guanosine derivatives targeting the influenza polymerase PB2 cap-binding domain publication-title: J. Med. Chem. doi: 10.1021/jm401369y – volume: 20 start-page: 3923 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0185 article-title: Viral RNA polymerase: a promising antiviral target for influenza A virus publication-title: Curr. Med. Chem. doi: 10.2174/09298673113209990208 – volume: 17 start-page: 383 year: 2001 ident: 10.1016/j.antiviral.2014.10.013_b0260 article-title: ATV: display and manipulation of annotated phylogenetic trees publication-title: Bioinformatics doi: 10.1093/bioinformatics/17.4.383 – volume: 178 start-page: 404 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0255 article-title: Polymerase complex with lysine at position 627 of the PB2 of influenza virus A/Hong Kong/483/97 (H5N1) efficiently transcribes and replicates virus genes in mouse cells publication-title: Virus Res. doi: 10.1016/j.virusres.2013.09.012 – volume: 6 start-page: 404 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0190 article-title: Influenza research database: an integrated bioinformatics resource for influenza research and surveillance publication-title: Influenza Other Respir. Viruses doi: 10.1111/j.1750-2659.2011.00331.x – volume: 8 start-page: e61957 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0090 article-title: Exploring the molecular epidemiology and evolutionary dynamics of influenza A virus in Taiwan publication-title: PLoS One doi: 10.1371/journal.pone.0061957 – volume: 7 start-page: e36113 year: 2012 ident: 10.1016/j.antiviral.2014.10.013_b0030 article-title: Functional analysis of conserved motifs in influenza virus PB1 protein publication-title: PLoS ONE doi: 10.1371/journal.pone.0036113 – volume: 14 start-page: 1188 year: 2004 ident: 10.1016/j.antiviral.2014.10.013_b0035 article-title: WebLogo: a sequence logo generator publication-title: Genome Res. doi: 10.1101/gr.849004 – volume: 8 start-page: e81027 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0240 article-title: Extreme evolutionary conservation of functionally important regions in H1N1 influenza proteome publication-title: PLoS One doi: 10.1371/journal.pone.0081027 – volume: 76 start-page: 280 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0235 article-title: The Site-Wise Log-Likelihood score is a good predictor of genes under positive selection publication-title: J. Mol. Evol. doi: 10.1007/s00239-013-9557-0 – volume: 87 start-page: 7200 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0115 article-title: Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier publication-title: J. Virol. doi: 10.1128/JVI.00980-13 – volume: 1 start-page: 9 year: 2010 ident: 10.1016/j.antiviral.2014.10.013_b0065 article-title: The emergence of pandemic influenza viruses publication-title: Protein & Cell doi: 10.1007/s13238-010-0008-z – volume: 85 start-page: 8569 year: 2011 ident: 10.1016/j.antiviral.2014.10.013_b0015 article-title: Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors publication-title: J. Virol. doi: 10.1128/JVI.00496-11 – volume: 87 start-page: 2455 year: 2013 ident: 10.1016/j.antiviral.2014.10.013_b0130 article-title: Identification of novel influenza A virus proteins translated from PA mRNA publication-title: J. Virol. doi: 10.1128/JVI.02656-12 – volume: 6 start-page: 87 year: 2001 ident: 10.1016/j.antiviral.2014.10.013_b0075 article-title: Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site publication-title: Genes Cells doi: 10.1046/j.1365-2443.2001.00399.x – volume: 148 start-page: 44 year: 2010 ident: 10.1016/j.antiviral.2014.10.013_b0155 article-title: Limited evidence of trans-hemispheric movement of avian influenza viruses among contemporary North American shorebird isolates publication-title: Virus Res. doi: 10.1016/j.virusres.2009.12.002 – volume: 57 start-page: 4337 year: 2014 ident: 10.1016/j.antiviral.2014.10.013_b9025 article-title: Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds publication-title: J. Med. Chem. doi: 10.1021/jm500300r – volume: 21 start-page: 337 year: 2008 ident: 10.1016/j.antiviral.2014.10.013_b0110 article-title: Nosocomial influenza: new concepts and practice publication-title: Curr. Opin. Infect. Dis. doi: 10.1097/QCO.0b013e3283013945 – volume: 8 start-page: 94 year: 2011 ident: 10.1016/j.antiviral.2014.10.013_b0045 article-title: Identification of novel conserved functional motifs across most influenza A viral strains publication-title: Virol. J. – volume: 13 start-page: 479 year: 2011 ident: 10.1016/j.antiviral.2014.10.013_b0210 article-title: Influenza genome diversity and evolution publication-title: Microbes Infect. doi: 10.1016/j.micinf.2011.01.013 – volume: 292 start-page: 1333 year: 2004 ident: 10.1016/j.antiviral.2014.10.013_b0200 article-title: Influenza-associated hospitalizations in the United States publication-title: JAMA doi: 10.1001/jama.292.11.1333 |
| SSID | ssj0006798 |
| Score | 2.1176705 |
| SecondaryResourceType | review_article |
| Snippet | •Polymorphism analyses reveal 12% and 6% conservation among viral polymerase nucleotide and protein sequences resp.•Identified 29 conserved nucleotide regions... Influenza virus is one of the major causes of mortality and morbidity associated with respiratory diseases. The high rate of mutation in the viral proteome... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 120 |
| SubjectTerms | Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences Computational Biology Conserved Sequence Drug targets Geotemporal sequence conservation Human viral diseases Infectious diseases Influenza polymerases Influenza protein druggability Influenza virus Medical sciences Orthomyxoviridae - enzymology Pharmacology. Drug treatments Phylogeography Protein Conformation RNA Replicase - chemistry RNA Replicase - genetics Sequence Analysis, DNA Sequence Analysis, Protein Viral diseases Viral diseases of the respiratory system and ent viral diseases Viral Proteins - chemistry Viral Proteins - genetics |
| Title | Global geno-proteomic analysis reveals cross-continental sequence conservation and druggable sites among influenza virus polymerases |
| URI | https://dx.doi.org/10.1016/j.antiviral.2014.10.013 https://www.ncbi.nlm.nih.gov/pubmed/25446404 https://www.proquest.com/docview/1634726036 https://www.proquest.com/docview/1647017177 |
| Volume | 112 |
| WOSCitedRecordID | wos000346943900012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1872-9096 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006798 issn: 0166-3542 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6DRASQjC-ykdlJMRLlSlN3HzwNqFOgLaCtE7qW-TEzppqTUvSVtue-Uf4T7mznbTVNjYeeIkit7Zb38_2-Xx3P0I-pLEXw64jYPVjqcWY61rcdrgluQNoToTwmFBkE36_HwyH4Y9G43cVC7M88_M8OD8PZ_9V1FAGwsbQ2X8Qd90oFMA7CB2eIHZ43knwOos_UiNPLZWFAeOO27xKPoIpmzBlstoeLfRUBz1ThURWXtXoiV7batXlgigWp6cqxgrvmkvDUJRpfpNL3l5mxaJEvocLNHGVxi2xTtGMBBWFIhBYM50p62ms3buPMIorlfIS3sZzKK3N2TwTmd4ExnxiLUrrmI940T7mgqcro8MoM82M-GTCxbolo8PWvEL04hv4jhXaoUmNfU1ZtWIbz2u95nZUNN3VvUCbJcZ7vPqb6MjH9tCXT4e_bmbf7n-PDk4OD6NBbzj4OPtpITEZDqphadkiO47fDWHh3Nn_2ht-q7d7vMbCU331QzecCK_t-yYV6NGMlzAxU82ocvORR6k-gyfksTmz0H2NtaekIfNdcl-zmF7skgdHxj_jGfmlwUc3wUcr8FEDPnoFfLQCH10HH1QUtAYfVeCjCny0Bh9V4KNr4HtOTg56g89fLMPzYSXMZXNLdlkIx34n6XiwMsSuDDtJ102FHSeelBJv9lG1T7nvuGnqO8h44NqCBXZiJ7HTcV-Q7Xyay1eEpq4TpowFnkBSdYaZN20v9KUn4lAIu9skXjX0UWKS4CMXy1lUeTuOo1pmEcoMPwCZNYldV5zpPDC3V_lUyTYy6qxWUyNA6O2VWxtoqDt1QrQ6ML9J3lfwiGBHwGs-nsvpoozghAUD5IFq-rfvMB8zZfnQzkuNrVUPXcY8ZrPXd-jhDXm4mslvyfa8WMh35F6ynGdl0SJb_jBomQnzB_S49t8 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+geno-proteomic+analysis+reveals+cross-continental+sequence+conservation+and+druggable+sites+among+influenza+virus+polymerases&rft.jtitle=Antiviral+research&rft.au=Babar%2C+Mustafeez+Mujtaba&rft.au=Zaidi%2C+Najam-us-Sahar+Sadaf&rft.au=Tahir%2C+Muhammad&rft.date=2014-12-01&rft.issn=1872-9096&rft.eissn=1872-9096&rft.volume=112&rft.spage=120&rft_id=info:doi/10.1016%2Fj.antiviral.2014.10.013&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0166-3542&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0166-3542&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0166-3542&client=summon |